Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$944M |
| 2 |
Amazon
AMZN
|
+$935M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$517M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$341M |
| 5 |
Netflix
NFLX
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.29B |
| 2 |
NVIDIA
NVDA
|
+$588M |
| 3 |
Bank of America
BAC
|
+$289M |
| 4 |
Intel
INTC
|
+$288M |
| 5 |
Union Pacific
UNP
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.77% |
| 2 | Technology | 1.83% |
| 3 | Communication Services | 1.58% |
| 4 | Consumer Discretionary | 1.42% |
| 5 | Healthcare | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
2876
PUT
DELISTED
Acceleron Pharma
XLRN
| $3.79M | ﹤0.01% |
97,000
+62,500
| +181% | +$2.66M |
|
|
DVAX
2877
DELISTED
Dynavax Technologies
DVAX
| $3.79M | ﹤0.01% |
190,908
+3,812
| +2% | +$65.8K |
|
2878
Kennametal
KMT
$2.3B
| $3.79M | ﹤0.01% |
+94,361
| New | +$4.31M |
|
|
MNI
2879
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $3.79M | ﹤0.01% |
409,759
+162,067
| +65% | +$1.46M |
|
2880
PUT
Red Robin
RRGB
$178M
| $3.78M | ﹤0.01% |
65,200
+3,400
| +6% | +$189K |
|
2881
iShares US Transportation ETF
IYT
$2.26B
| $3.77M | ﹤0.01% |
80,732
+57,612
| +249% | +$2.78M |
|
2882
PUT
Affiliated Managers Group
AMG
$9.58B
| $3.77M | ﹤0.01% |
19,900
+15,500
| +352% | +$3.02M |
|
|
EGRX
2883
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.77M | ﹤0.01% |
71,600
+25,000
| +54% | +$1.45M |
|
2884
CALL
QuidelOrtho
QDEL
$1.05B
| $3.77M | ﹤0.01% |
72,700
+32,500
| +81% | +$1.51M |
|
2885
CALL
DTE Energy
DTE
$28.3B
| $3.76M | ﹤0.01% |
42,300
+21,855
| +107% | +$1.92M |
|
|
PDCO
2886
PUT
DELISTED
Patterson Companies, Inc.
PDCO
| $3.75M | ﹤0.01% |
168,900
+119,800
| +244% | +$3.73M |
|
|
PRMW
2887
CALL
DELISTED
Primo Water Corporation
PRMW
| $3.75M | ﹤0.01% |
254,900
+42,100
| +20% | +$668K |
|
|
SRCL
2888
CALL
DELISTED
Stericycle Inc
SRCL
| $3.75M | ﹤0.01% |
64,100
+3,100
| +5% | +$210K |
|
2889
PUT
Landstar System
LSTR
$6.17B
| $3.75M | ﹤0.01% |
34,200
+29,500
| +628% | +$3.23M |
|
|
PAY
2890
DELISTED
Verifone Systems Inc
PAY
| $3.75M | ﹤0.01% |
243,819
+102,087
| +72% | +$1.78M |
|
2891
CALL
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.97B
| $3.75M | ﹤0.01% |
28,200
+9,000
| +47% | +$1.23M |
|
|
DST
2892
CALL
DELISTED
DST Systems Inc.
DST
| $3.75M | ﹤0.01% |
44,800
+28,200
| +170% | +$2.29M |
|
2893
GoPro
GPRO
$112M
| $3.75M | ﹤0.01% |
+782,357
| New | +$4.48M |
|
|
2894
CALL
Red Robin
RRGB
$178M
| $3.75M | ﹤0.01% |
64,600
+20,500
| +46% | +$1.14M |
|
|
AIMT
2895
CALL
DELISTED
Aimmune Therapeutics
AIMT
| $3.75M | ﹤0.01% |
117,700
+76,100
| +183% | +$2.68M |
|
2896
Aflac
AFL
$58.4B
| $3.74M | ﹤0.01% |
85,433
+3,843
| +5% | +$170K |
|
2897
PUT
New York Times
NYT
$11B
| $3.74M | ﹤0.01% |
155,100
+115,400
| +291% | +$2.65M |
|
|
KLXI
2898
CALL
DELISTED
KLX Inc.
KLXI
| $3.74M | ﹤0.01% |
62,384
-25,973
| -29% | -$1.52M |
|
|
DVAX
2899
PUT
DELISTED
Dynavax Technologies
DVAX
| $3.73M | ﹤0.01% |
188,100
-144,100
| -43% | -$2.49M |
|
2900
PUT
Pentair
PNR
$9.91B
| $3.73M | ﹤0.01% |
81,597
+19,506
| +31% | +$929K |
|
Similar funds
Jeff Yass's Q1 2018 Portfolio in Review
As of Q1 2018, Jeff Yass held 10,979 positions worth $281B, down 1% from $283B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q1 2018 filing shows 1,821 new, 3,804 increased, 3,502 reduced and 1,753 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M. The largest sale was Apple, an estimated $1.29B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q1 2018 buy was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q1 2018, an estimated $944M increase.
- Jeff Yass's biggest Q1 2018 reduction was Apple, cutting an estimated $1.29B.
- Jeff Yass fully exited iShares MSCI Japan ETF in Q1 2018, selling an estimated $84.1M.
- Jeff Yass's ten largest holdings make up 27% of its $281B portfolio in Q1 2018.
- Jeff Yass opened 1,821 new positions and closed 1,753 in Q1 2018.
- Jeff Yass's portfolio value fell 1% quarter-over-quarter to $281B.
Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.